What is she best known for?
The fields of study Julie M. Vose is best known for:
Many of her studies involve connections with topics such as Adverse effect and Internal medicine.
In her study, she carries out multidisciplinary Oncology and Cancer research research.
She performs multidisciplinary studies into Cancer research and Oncology in her work.
Julie M. Vose conducted interdisciplinary study in her works that combined Immunology and Immune system.
Immune system is frequently linked to Peripheral T-cell lymphoma in her study.
She merges Peripheral T-cell lymphoma with T cell in her study.
In her works, Julie M. Vose conducts interdisciplinary research on T cell and Immunology.
In her study, she carries out multidisciplinary Chemotherapy and Neutropenia research.
She performs multidisciplinary study in Diffuse large B-cell lymphoma and International Prognostic Index in her work.
Her most cited work include:
- Revised Response Criteria for Malignant Lymphoma (3812 citations)
- The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma (3357 citations)
- International Peripheral T-Cell and Natural Killer/T-Cell Lymphoma Study: Pathology Findings and Clinical Outcomes (1634 citations)
What are the main themes of her work throughout her whole career to date
Internal medicine is often connected to Neutropenia in her work.
In her study, she carries out multidisciplinary Oncology and Cancer research research.
Julie M. Vose performs integrative study on Cancer research and Oncology.
Julie M. Vose undertakes interdisciplinary study in the fields of Chemotherapy and Rituximab through her research.
In her works, Julie M. Vose undertakes multidisciplinary study on Gastroenterology and Internal medicine.
By researching both Immunology and Antibody, Julie M. Vose produces research that crosses academic boundaries.
Julie M. Vose brings together Surgery and Chemotherapy to produce work in her papers.
Her Transplantation study frequently draws parallels with other fields, such as Hematopoietic stem cell transplantation.
Her study brings together the fields of Transplantation and Hematopoietic stem cell transplantation.
Julie M. Vose most often published in these fields:
- Internal medicine (89.75%)
- Lymphoma (79.15%)
- Oncology (60.78%)
What were the highlights of her more recent work (between 2018-2022)?
- Internal medicine (81.08%)
- Lymphoma (78.38%)
- Oncology (62.16%)
In recent works Julie M. Vose was focusing on the following fields of study:
Julie M. Vose regularly ties together related areas like Chimeric antigen receptor in her Internal medicine studies.
In her research, she undertakes multidisciplinary study on Lymphoma and Mantle cell lymphoma.
She integrates many fields in her works, including Oncology and Gastroenterology.
She performs multidisciplinary study in the fields of Gastroenterology and Oncology via her papers.
Her study deals with a combination of Immunology and Pathology.
Julie M. Vose undertakes multidisciplinary studies into Pathology and Immunology in her work.
In her articles, she combines various disciplines, including Cancer research and Genetics.
Julie M. Vose conducts interdisciplinary study in the fields of Genetics and Cancer research through her works.
Her study in Astrobiology extends to Refractory (planetary science) with its themes.
Between 2018 and 2022, her most popular works were:
- Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium (358 citations)
- The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee (168 citations)
- Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma (141 citations)
In her most recent research, the most cited works focused on:
- Cancer
- Chemotherapy
- Lymphoma
In her study, Julie M. Vose carries out multidisciplinary Lymphoma and Targeted therapy research.
She merges Targeted therapy with Lymphoma in her study.
Internal medicine and Intensive care medicine are two areas of study in which she engages in interdisciplinary research.
Intensive care medicine and Internal medicine are two areas of study in which Julie M. Vose engages in interdisciplinary work.
Her Oncology study frequently involves adjacent topics like Chemotherapy regimen.
The study of Chemotherapy regimen is intertwined with the study of Oncology in a number of ways.
Cancer research and Leukemia are two areas of study in which she engages in interdisciplinary work.
Her work blends Leukemia and Cancer research studies together.
Her Immunology study frequently involves adjacent topics like Diffuse large B-cell lymphoma.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
